Various Clinical Manifestations in a Heterozygous Fabry Disease Family: From Asymptomatic to Acute Ischemic Stroke with Intracranial Cerebral Artery Stenosis by 이경열
Copyright © 2020 Korean Neurological Association  505
JCN  Open Access
Various Clinical Manifestations in a Heterozygous Fabry 
Disease Family: From Asymptomatic to Acute Ischemic Stroke 
with Intracranial Cerebral Artery Stenosis
Dear Editor, 
Fabry disease (FD) is a rare X-linked recessive lysosomal storage disorder characterized 
by decreased or absent activity of lysosomal α-galactosidase A (GLA), which results in ac-
cumulation of the glycolipid in various types of cell.1 The estimated prevalence of FD at birth 
has ranged from 1:40,000 to 1:170,000, and its prevalence is about 4% in patients with cryp-
togenic stroke aged between 18 and 55 years.2,3 Here we report a heterozygous FD family 
with various clinical manifestations from asymptomatic to acute ischemic stroke due to in-
tracranial cerebral artery stenosis.
A previously healthy 36-year-old female (patient 1) was admitted with left hemiparesis. 
Her initial National Institutes of Health Stroke Scale score was 6 points, and her vital signs 
were stable except for elevated blood pressure at 149/100 mm Hg. Her own medical history 
was unremarkable, but her family history was significant for ischemic stroke in her grand-
father, father, and uncle. Brain magnetic resonance imaging (MRI) revealed an acute infarc-
tion in the right middle cerebral artery (MCA) territory (Fig. 1A). Subsegmental narrowing 
of the right proximal MCA and anterior cerebral artery (ACA) was revealed by brain mag-
netic resonance angiography (MRA) (Fig. 1B) and digital subtraction angiography (DSA, 
Fig. 1C). GLA activity using a dried blood spot was within the normal range (3.16 µmol/h/L; 
normal range ≥1.32 µmol/h/L).
The 61-year-old mother of patient 1 (patient 2) took medication for hypertension and 
dyslipidemia. MRI and MRA detected multifocal hyperintense lesions in the white matter 
in fluid-attenuated inversion recovery imaging, while no remarkable stenosis was seen in 
brain MRA. Her GLA activity was within the normal range (5.94 µmol/h/L). The 33-year-
old brother of patient 1 (patient 3) had no medical history. Brain MRI produced unremark-
able findings, but brain MRA (Fig. 1D) and DSA (Fig. 1E and F) revealed segmental steno-
sis in the right MCA and a tortuous vertebrobasilar artery. His GLA activity was within the 
normal range (4.03 µmol/h/L). 
The pedigrees of the family are shown in Fig. 1G. An ophthalmological examination, kid-
ney ultrasonography, and peripheral nerve conduction study produced no remarkable find-
ings in any patient. The molecular analysis of the GLA gene revealed a genotype of p.E66Q 
(c.G196C, p.Glu66Gln) on exon 2 (heterozygote in patients 1 and 2, and hemizygote in pa-
tient 3). After genetic testing we again performed fluorimetry, which revealed low GLA ac-
tivity in patient 3 (9.8 μmol/L/h, normal range ≥15.3 μmol/L/h). Another genetic factor in-
volved in vessel stenosis in young adults, the ring finger protein 213 gene, is strongly associated 
with Moyamoya disease, but this was not detected in patients 1 and 3. 
The present family exhibited various clinical phenotypes of heterozygous FD. The cere-
bral manifestations of FD can be classified as either large- or small-vessel disease.4 Acute 
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ischemic stroke due to large intracranial artery stenosis is a 
novel finding in FD because most ischemic strokes in FD oc-
cur within small vessels.5
The severity of FD manifestations in heterozygous female 
patients is complex due to the process of X chromosome in-
activation (XCI).4 Both random and skewed patterns of XCI 
have been reported in female heterozygous FD patients.4 Pa-
tients with the random XCI pattern exhibit age-dependent 
worsening of clinical manifestations, whereas the skewed XCI 
pattern leads to the predominant expression of the wild-type 
GLA gene, and these patients exhibit an attenuated clinical 
phenotype in which disease progression is not correlated with 
age.4
More than 600 different mutations are known to exist in the 
GLA gene.4 The p.E66Q GLA gene mutation detected in the 
present study is considered to be nonpathogenic based on its 
in vitro expression and prevalence in healthy alleles.2 However, 
p.E66Q variants could be considered pathogenic because of 
the complexity of the GLA gene and gene–environment inter-
actions.2
We have reported a case series involving a heterozygous FD 
family that revealed the various clinical expressions of FD, 
with ischemic stroke as the most-serious disease manifestation.
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Fig. 1. Imaging studies and family pedigree of the patients. A: Diffusion-weighted imaging of patient 1 revealed a high-signal-intensity lesion in the 
right MCA territory involving the basal ganglia. B: Brain MRA revealed subsegmental stenosis (white arrow) in the right MCA and ACA. C: DSA also 
demonstrated severe stenosis (black arrow) in the right proximal MCA and ACA. D: Brain MRA revealed segmental stenosis (white arrowhead) in the 
right MCA of patient 3. E: DSA showed stenosis (black arrowhead) in the right MCA of patient 3. F: DSA showed the tortuous vertebrobasilar artery of 
patient 3. G: The family pedigree. ACA: anterior cerebral artery, DSA: digital subtraction angiography, MCA: middle cerebral artery, MRA: magnetic res-
onance angiography.
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